Hepatitis C virus in Mexican Americans: A population-based study reveals relatively high prevalence and negative association with diabetes

Epidemiology and Infection

Volumn 144, Issue 2, 2016, Pages 297-305

  Watt, G P ^a   Vatcheva, K P ^a   Beretta, L ^b   Pan, J J ^c   Fallon, M B ^c   McCormick, J B ^a   Fisher Hoch, S P ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Hepatitis C virus; infectious disease epidemiology; Mexican American; prevalence of disease; public health

Indexed keywords

VIRUS ANTIBODY; HEPATITIS C ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICAN AMERICAN; MEXICO; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; UNITED STATES; BLOOD; COINFECTION; CROSS-SECTIONAL STUDY; HEPACIVIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; PREVALENCE; VIROLOGY;

ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; PREVALENCE; RISK FACTORS; TEXAS;

EID: 84949533964     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815001247     Document Type: Article

References (35)

1. Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annual Review of Pathology: Mechanisms of Disease 2006; 1: 23-61.
2. Alter M. Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology 2007; 13: 2436-2441.
3. Armstrong GL, et al. The prevalence of hepatitis C vrus infection in the united states, 1999 through 2002. Annals of Internal Medicine 2006; 144: 705-W162.
4. Klevens RM, et al. Evolving epidemiology of hepatitis C virus in the United States. Clinical Infectious Disease 2012; 55 (Suppl. 1): S3-S9.
5. Colvin HM, Mitchell AE (eds). Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Press, 2010, pp. 232.
6. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36: S21-S29.
7. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-S46.
8. Kuniholm MH, et al. Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL Studies. Journal of Infectious Diseases 2014; 209: 1585-1590.
9. Centers for Disease Control and Prevention. Surveillance for viral hepatitis-United States, 2011. Division of Viral Hepatitis (http://www.cdc.gov/hepatitis/Statistics/ 2011Surveillance/Commentary.htm).
10. Pan J-J, et al. Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: A population-based study. PLoS ONE 2011; 6: e21515.
11. Perez A, et al. High frequency of chronic end-stage liver disease and hepatocellular carcinoma in a Hispanic population. Journal of Gastroenterology and Hepatology 2004; 19: 289-295.
12. Fisher-Hoch SP, et al. Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007. Preventing Chronic Disease 2010; 7: A53.
13. Fisher-Hoch SP, et al. Missed opportunities for diagnosis and treatment of diabetes, hypertension, and hypercholesterolemia in a Mexican American population, Cameron County Hispanic Cohort, 2003-2008. Preventing Chronic Disease 2012; 9 (E135).
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl. 1): S62-S69.
15. Centers for Disease Control and Prevention. Surveillance data for acute viral hepatitis-United States, 2009. Viral hepatitis statistics and surveillance, 2012 (http://www. cdc.gov/hepatitis/Statistics/2009Surveillance/index.htm).
16. Wallisch LS, Spence RT. Alcohol and drug use, abuse, and dependence in urban areas and colonias of the Texas-Mexico border. Hispanic Journal of Behavioral Science 2006; 28: 286-307.
17. Clark S. Census Bureau: Brownsville poorest city in U.S. Brownsville Herald. Brownsville, TX, 7 November 2013 (http://www.brownsvilleherald.com/news/local/article-b630f374-475c-11e3-a86e-001a4bcf6878.html).
18. Sauter AEMH, Frohlich TC, Michael B. America's richest (and poorest) cities. 24/7 Wall Street, 2013 (http:// 247wallst.com/special-report/2013/10/24/americas-therichest-and-poorest-cities/).
19. US Census Bureau. Brownsville, Texas. State and county quick facts, 2014 (http://quickfacts.census.gov/ qfd/states/48/4810768.html).
20. Kershenobich D, et al. Trends and projections of hepatitis C virus epidemiology in Latin America. Liver International 2011; 31: 18-29.
21. Valdespino JL, et al. Seroprevalence of hepatitis C in Mexican adults: an emerging public health problem? Salud Pública de México 2007; 49: S395-S403.
22. Burguete-García AI, et al. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Salud Pública de México 2011; 53: 7-12.
23. Coffin PO, et al. Cost-effectiveness and population outcomes of general population screening for hepatitis C. Clinical Infectious Diseases 2012; 54: 1259-1271.
24. Antonelli A, et al. Hepatitis C virus infection evidence for an association with type 2 diabetes. Diabetes Care 2005; 28: 2548-2550.
25. Knobler H, et al. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus Infection. Mayo Clinic Proceedings 2000; 75: 355-359.
26. Shintani Y, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-848.
27. Mangia A, et al. HCV and diabetes mellitus: evidence for a negative association. American Journal of Gastroenterology 1998; 93: 2363-2367.
28. Ruhl CE, et al. Relationship of hepatitis C virus infection with diabetes in the U.S. population. Hepatology 2014; 60: 1139-1149.
29. Mhatre A. The association between diabetes and hepatitis C: A systematic review of epidemiological evidence (dissertation). Ann Arbor, United States, 2008, 40 pp.
30. Adegoke OA, et al. Seroprevalence of hepatitis C virus infection in Nigerians with type 2 diabetes mellitus. Nigerian Journal of Clinical Practice 2008; 11: 199-201.
31. Hourigan LF, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-1219.
32. Hui JM, et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003; 125: 1695-1704.
33. Ratziu V, et al. Fibrogenic impact of high serum glucose in chronic hepatitis C. Journal of Hepatology 2003; 39: 1049-1055.
34. D'souza R, Sabin C, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. American Journal of Gastroenterology. 2005; 100: 1509-1515.
35. Qu H-Q, et al. The definition of insulin resistance using HOMA-IR for Americans of Mexican Descent using machine learning. PLoS ONE 2011; 6: e21041.